The global cellular health screening market was valued at USD 2.78 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 9.2% from 2023 to 2030. Over this period, the importance of precision medicine is expected to increase, driven by the rising need to analyze biomarkers associated with aging and overall cellular health. Cellular health screening plays a crucial...